Jess S. Morgan & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$3.46M |
| 2 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$3.05M |
| 3 |
AGEN
Agenus
AGEN
|
+$2.24M |
| 4 |
CKPT
Checkpoint Therapeutics
CKPT
|
+$2M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily Small Cap Bull 3x ETF
TNA
|
+$1.79M |
| 2 |
Oramed Pharmaceuticals
ORMP
|
+$1.62M |
| 3 |
Cheesecake Factory
CAKE
|
+$1.23M |
| 4 |
iShares Semiconductor ETF
SOXX
|
+$418K |
| 5 |
NovoCure
NVCR
|
+$356K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.53% |
| 2 | Technology | 9.88% |
| 3 | Financials | 8.61% |
| 4 | Consumer Discretionary | 5.31% |
| 5 | Communication Services | 4.45% |
Similar funds
Jess S. Morgan & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Jess S. Morgan & Co held 44 positions worth $143M, up 14% from $126M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jess S. Morgan & Co deployed $10.2M of net new capital in Q1 2021, opening 4 new positions and adding to 23 existing holdings. Its largest new stake was Paramount Global Class B: 56,645 shares worth $2.56M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Direxion Daily Small Cap Bull 3x ETF, an estimated $1.79M trimmed.
- Jess S. Morgan & Co's largest Q1 2021 buy was Paramount Global Class B: 56,645 shares worth $2.56M.
- Jess S. Morgan & Co added most to Vanguard Total International Stock ETF in Q1 2021, an estimated $1.1M increase.
- Jess S. Morgan & Co's biggest Q1 2021 reduction was Direxion Daily Small Cap Bull 3x ETF, cutting an estimated $1.79M.
- Jess S. Morgan & Co's ten largest holdings make up 32% of its $143M portfolio in Q1 2021.
- Jess S. Morgan & Co opened 4 new positions and closed 0 in Q1 2021.
- Jess S. Morgan & Co's portfolio value rose 14% quarter-over-quarter to $143M.
Based on Jess S. Morgan & Co's 13F filing for Q1 2021, filed 30 Nov 2021.